In OPSCC and oral cancer, S100A8/S100A9 is often downregulated, associated with lower tumor grading, upregulation of apoptosis-related genes, decreased EGFR expression, epithelial differentiation and decreased migration and invasion35,36. Here, S100A9 is linked to neoplasm.